{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-205370","form_type":"8-K","ticker":"WHWK","cik":"0001422142","company_name":"Whitehawk Therapeutics, Inc.","filed_at":"2024-08-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.005242+00:00","generated_at":"2026-05-31T08:02:46.468399+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CMO Loretta Itri resigns; Executive Chairman Neil Desai steps down on Oct 1, 2024","bullets":["CMO Dr. Loretta Itri voluntarily resigns effective Oct 1, 2024; receives 12 months severance pay plus COBRA reimbursement.","Executive Chairman Neil Desai terminated effective Oct 1, 2024; receives severance per agreement; remains on board.","Dr. Itri enters consulting arrangement: 10 hrs/month, $8,000 monthly retainer, initial 3-month term.","Both executives continue vesting in equity awards during consulting/board service."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-205370","json":"https://secwatch.observer/filing/0001193125-24-205370.json","markdown":"https://secwatch.observer/filing/0001193125-24-205370.md","text":"https://secwatch.observer/filing/0001193125-24-205370.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1422142/000119312524205370/0001193125-24-205370-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1422142/000119312524205370/d884557d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T08:02:46.468399+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"27682285c8","claim":"Loretta Itri resigned as Chief Medical Officer at Whitehawk Therapeutics, Inc..","evidence_excerpt":"On August 16, 2024, Loretta Itri, M.D. notified the board of directors of the Company (the “Board”) that her employment as Chief Medical Officer will cease effective October 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1422142/000119312524205370/0001193125-24-205370-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Medical Officer"}],"fact_type":"executive_change"},{"claim_id":"40a5a8e631","claim":"Neil Desai was terminated as Executive Chairman at Whitehawk Therapeutics, Inc..","evidence_excerpt":"On August 20, 2024, Neil Desai, Ph.D, was notified that his employment as Executive Chairman of the Company will cease on October 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1422142/000119312524205370/0001193125-24-205370-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Executive Chairman"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}